1018826-32-8

Basic information

• Product Name: tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate
• Synonyms: tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate
• CAS NO: 1018826-32-8
• Molecular Weight: 486.416
• Mol File: 1018826-32-8.mol
• Article Data: 8

Chemical Properties

• CAS DataBase Reference: tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate(1018826-32-8)
• EPA Substance Registry System: tert-butyl 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)methoxy)-acetate(1018826-32-8)

Safety Data

• Hazardous Substances Data: 1018826-32-8(Hazardous Substances Data)

Upstream product

• 4620-34-2 ethyl 1,2,3,4-tetrahydroquinoline-2-carboxylate 
• 63430-96-6 1,2,3,4-tetrahydroquinolin-2-ylmethanol 
• 5292-43-3 bromoacetic acid tert-butyl ester 
• 1018826-31-7 [1-(3,4-dichloro-phenylsulfonyl)-1,2,3,4-tetrahydro-quinolin-2-yl]-methanol 

Downstream Products

• 1018826-33-9 2-((1-(3,4-dichlorophenylsulfonyl)-1,2,3,4-tetrahydroquinolin-2-yl)-methoxy)acetic acid 

Relevant articles and documents

SUBSTITUTED SULFONAMIDE DERIVATIVES

The invention relates to substituted sulfonamide derivatives, processes for the preparation thereof, medicaments containing these compounds and the use of substituted sulfonamide derivatives for the preparation of medicaments.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to the formula I: processes for the preparation thereof, pharmaceutical composition containing these compounds and the use of substituted sulfonamide compounds for the preparation of pharmaceutical compositions.

Substituted Sulfonamide Compounds

Substituted sulfonamide compounds corresponding to formula I: a process for their preparation, pharmaceutical compositions comprising such compounds, and the use of such substituted sulfonamide compounds in pharmaceutical compositions for the treatment of pain or other disorders or diseases that are mediated at least in part by B1R receptors.